Glooko
CA - Palo AltoBiotechnology
Focus: Glooko is a digital health company specializing in glucose monitoring and diabetes management applications, operating as a public company in the metabolic disease space.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at Glooko?
AI assessmentConsider only if you have direct connection to leadership or are evaluating pre-inflection digital health opportunities; current hiring freeze is a significant red flag.
Why Work Here
- Pioneering digital health platform in high-prevalence metabolic disease market with 4 active clinical programs
- Public company status provides equity transparency and potential liquidity events
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Glooko Mobile Insulin Dosing System
Type 2 Diabetes MellitusClinical Trials (1)
NCT03091712Insulin Degludec Titration Using Mobile Insulin Dosing System
N/AHelp build intelligence for Glooko
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.